Cero Therapeutics Holdings Stock Market Value
| CEROW Stock | 0.01 0 14.29% |
| Symbol | CERo |
CERo Therapeutics Price To Book Ratio
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CERo Therapeutics. If investors know CERo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CERo Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Return On Assets (0.45) |
The market value of CERo Therapeutics is measured differently than its book value, which is the value of CERo that is recorded on the company's balance sheet. Investors also form their own opinion of CERo Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is CERo Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CERo Therapeutics' market value can be influenced by many factors that don't directly affect CERo Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CERo Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if CERo Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CERo Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
CERo Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to CERo Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of CERo Therapeutics.
| 09/22/2024 |
| 12/21/2024 |
If you would invest 0.00 in CERo Therapeutics on September 22, 2024 and sell it all today you would earn a total of 0.00 from holding CERo Therapeutics Holdings or generate 0.0% return on investment in CERo Therapeutics over 90 days. CERo Therapeutics is related to or competes with Viking Therapeutics, Vanda Pharmaceuticals, Verrica Pharmaceuticals, Viridian Therapeutics, Verona Pharma, Virpax Pharmaceuticals, and Vertex Pharmaceuticals. CERo Therapeutics is entity of United States More
CERo Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure CERo Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess CERo Therapeutics Holdings upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 25.5 | |||
| Information Ratio | 0.1397 | |||
| Maximum Drawdown | 191.74 | |||
| Value At Risk | (40.00) | |||
| Potential Upside | 66.67 |
CERo Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for CERo Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as CERo Therapeutics' standard deviation. In reality, there are many statistical measures that can use CERo Therapeutics historical prices to predict the future CERo Therapeutics' volatility.| Risk Adjusted Performance | 0.1212 | |||
| Jensen Alpha | 5.11 | |||
| Total Risk Alpha | 4.04 | |||
| Sortino Ratio | 0.1969 | |||
| Treynor Ratio | (1.73) |
CERo Therapeutics Backtested Returns
CERo Therapeutics is out of control given 3 months investment horizon. CERo Therapeutics secures Sharpe Ratio (or Efficiency) of 0.13, which signifies that the company had a 0.13% return per unit of risk over the last 3 months. We were able to break down and interpolate data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 4.75% are justified by taking the suggested risk. Use CERo Therapeutics risk adjusted performance of 0.1212, and Mean Deviation of 26.34 to evaluate company specific risk that cannot be diversified away. CERo Therapeutics holds a performance score of 10 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -2.91, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning CERo Therapeutics are expected to decrease by larger amounts. On the other hand, during market turmoil, CERo Therapeutics is expected to outperform it. Use CERo Therapeutics value at risk, as well as the relationship between the kurtosis and price action indicator , to analyze future returns on CERo Therapeutics.
Auto-correlation | -0.34 |
Poor reverse predictability
CERo Therapeutics Holdings has poor reverse predictability. Overlapping area represents the amount of predictability between CERo Therapeutics time series from 22nd of September 2024 to 6th of November 2024 and 6th of November 2024 to 21st of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of CERo Therapeutics price movement. The serial correlation of -0.34 indicates that nearly 34.0% of current CERo Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.34 | |
| Spearman Rank Test | -0.07 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
CERo Therapeutics lagged returns against current returns
Autocorrelation, which is CERo Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting CERo Therapeutics' stock expected returns. We can calculate the autocorrelation of CERo Therapeutics returns to help us make a trade decision. For example, suppose you find that CERo Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
CERo Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If CERo Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if CERo Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in CERo Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
CERo Therapeutics Lagged Returns
When evaluating CERo Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of CERo Therapeutics stock have on its future price. CERo Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, CERo Therapeutics autocorrelation shows the relationship between CERo Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in CERo Therapeutics Holdings.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for CERo Stock Analysis
When running CERo Therapeutics' price analysis, check to measure CERo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CERo Therapeutics is operating at the current time. Most of CERo Therapeutics' value examination focuses on studying past and present price action to predict the probability of CERo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CERo Therapeutics' price. Additionally, you may evaluate how the addition of CERo Therapeutics to your portfolios can decrease your overall portfolio volatility.